Home / Resources (page 70)

Resources

RESOURCES

Tirzepatide: A Dual GLP-1/GIP Receptor Agonist for the Treatment of T2D

Authors: Ashley Wagnild, PharmD Candidate 2024, Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP Department of Pharmacotherapy College of Pharmacy and Pharmaceutical Sciences Washington State University A 54-year-old man was referred to the pharmacotherapy clinic by his primary care provider (PCP) for a therapy consult. The patient had a past medical …

Read More »

Sickle Cell Disease and Diabetes Mellitus

Is there a link between patients living with sickle cell disease and diabetes mellitus? African-Americans/ Black are the most affected by sickle cell disease (SCD). According to the US Department of Health and Human Services Office of Minority Health, this population also has the highest prevalence of obesity. Sickle cell …

Read More »

Comparison of Patients with Diabetes in Rural and Urban Populations

Socioeconomic status has always had an impact on patient outcomes. “Although national mortality rates have generally declined in the past few decades, the urban-rural disparity in life expectancy has widened, with greater improvements in urban areas than rural” (Mercado et al.). The study conducted by Mercado et al. analyzed data …

Read More »

Relationship between Diabetes and infection-related hospitalizations

Diabetes is linked with an increased risk of common and rare infections… Diabetes increases the likelihood of infection by damaging neutrophil performance, antioxidant systems, and humoral immune response. Diabetes Guidelines focus on preventing microvascular and macrovascular complications. There is less emphasis on the role of Diabetes as it pertains to …

Read More »

Increased Risk Of Hospitalization For Infection Seen With Diabetic Patients

Does diabetes increase a patient’s risk for being hospitalized for infections compared to non-diabetics? Increase risk of common and rare infections are associated with patients living with diabetes. There is general reasoning that patients with diabetes are susceptible to infection because of impaired neutrophil functioning, antioxidant systems, and humoral immune …

Read More »

The Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone: A New Option for Patients with Diabetic Kidney Disease

Allison S. Rembert, PharmD Candidate 2024 Adrian K. Baker, PharmD Candidate 2024 Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP Department of Pharmacotherapy College of Pharmacy and Pharmaceutical Sciences Washington State University A 55-year-old female with type 2 diabetes (T2D) and chronic kidney disease (CKD) presented to the ambulatory care clinic. …

Read More »